About 4 results found for searched term "57-63-6" (0.298 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2551 | LY573636 (Tasisulam) | Caspase |
| Tasisulam | ||
| LY573636 is a novel anticancer agent that induces apoptosis through the intrinsic pathway and has antiangiogenic activity in preclinical models. | ||
| M3392 | Ethinyl Estradiol | Estrogen Receptor |
| 17α-Ethynylestradiol; Ethynylestradiol | ||
| Ethinyl Estradiol (Ethinylestradiol) is an orally bio-active estrogen used in almost all modern formulations of combined oral contraceptive pills. | ||
| M28387 | SBP-0636457 | IAP |
| SBI-0636457; SB1-0636457 | ||
| SBP-0636457 (SB1-0636457) is a SMAC mimetic, and as an IAP antagonist. SBP-0636457 binds to the BIR-domains of the IAP proteins, with a Ki of 0.27 μM. SBP-0636457 can be used for the research of solid tumors and hematologic cancers. | ||
| M30230 | Tasisulam sodium | Apoptosis |
| LY 573636 sodium | ||
| Tasisulam is a anticancer agent and induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. Tasisulam inhibits mitotic progression and induces vascular normalization. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
